BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 22100669)

  • 1. Assimilating the current clinical data of fully bioabsorbable stents.
    Di Mario C; Borgia F
    EuroIntervention; 2009 Dec; 5 Suppl F():F103-8. PubMed ID: 22100669
    [No Abstract]   [Full Text] [Related]  

  • 2. Everolimus-eluting bioabsorbable stent--Abbot Vascular programme.
    Onuma Y; Piazza N; Ormiston JA; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F98-F102. PubMed ID: 22100687
    [No Abstract]   [Full Text] [Related]  

  • 3. Bioabsorbable drug-eluting stents: the future of coronary angioplasty?
    Macaya C; Moreno R
    Nat Clin Pract Cardiovasc Med; 2008 Oct; 5(10):598-9. PubMed ID: 18679382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NEVO™: a new generation of sirolimus-eluting coronary stent.
    Falotico R; Parker T; Grishaber R; Price S; Cohen SA; Rogers C
    EuroIntervention; 2009 Dec; 5 Suppl F():F88-93. PubMed ID: 22100684
    [No Abstract]   [Full Text] [Related]  

  • 5. More openness and a little less strut: two good ideas for stents and the people who implant them.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Nov; 76(5):652-3. PubMed ID: 20976746
    [No Abstract]   [Full Text] [Related]  

  • 6. Bioabsorbable coronary stents.
    Ormiston JA; Serruys PW
    Circ Cardiovasc Interv; 2009 Jun; 2(3):255-60. PubMed ID: 20031723
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
    Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
    Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Another small step for small vessels.
    Morrison DA
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):67-9. PubMed ID: 20578195
    [No Abstract]   [Full Text] [Related]  

  • 9. Elixir Medical's bioresorbable drug eluting stent (BDES) programme: an overview.
    Yan J; Bhat VD
    EuroIntervention; 2009 Dec; 5 Suppl F():F80-2. PubMed ID: 22100682
    [No Abstract]   [Full Text] [Related]  

  • 10. PCI in small vessels: the case for a drug-coated balloon based intervention.
    Zeymer U; Scheller B
    EuroIntervention; 2011 May; 7 Suppl K():K57-60. PubMed ID: 22027729
    [No Abstract]   [Full Text] [Related]  

  • 11. Nevo stent: a successful stent makeover.
    Belardi JA
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):52-3. PubMed ID: 21181969
    [No Abstract]   [Full Text] [Related]  

  • 12. The Kounis syndrome in everolimus-eluting stents and paclitaxel-eluting stents.
    Kounis NG; Giannopoulos S; Goudevenos JA
    Catheter Cardiovasc Interv; 2010 Dec; 76(7):1076-7; author reply 1078. PubMed ID: 21086494
    [No Abstract]   [Full Text] [Related]  

  • 13. OrbusNeich fully absorbable coronary stent platform incorporating dual partitioned coatings.
    Cottone RJ; Thatcher GL; Parker SP; Hanks L; Kujawa DA; Rowland SM; Costa M; Schwartz RS; Onuma Y
    EuroIntervention; 2009 Dec; 5 Suppl F():F65-71. PubMed ID: 22100679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral sirolimus after bare metal stent implantation: a glimpse to the future.
    Mieres J
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):158-9. PubMed ID: 20931667
    [No Abstract]   [Full Text] [Related]  

  • 15. Current state of the absorbable metallic (magnesium) stent.
    Waksman R
    EuroIntervention; 2009 Dec; 5 Suppl F():F94-7. PubMed ID: 22100686
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local drug delivery for treatment of coronary and peripheral artery disease.
    Gertz ZM; Wilensky RL
    Cardiovasc Ther; 2011 Dec; 29(6):e54-66. PubMed ID: 20553281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective randomised study using optical coherence tomography to assess endothelial coverage and neointimal proliferation at 6-months after implantation of a coronary everolimus-eluting stent compared with a bare metal stent postdilated with a paclitaxel-eluting balloon (OCTOPUS Trial): rationale, design and methods.
    Poerner TC; Otto S; Gassdorf J; Janiak F; Danzer C; Ferrari M; Figulla HR
    EuroIntervention; 2011 May; 7 Suppl K():K93-9. PubMed ID: 22027737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sirolimus- versus paclitaxel-eluting stents for unselected patients with coronary artery disease.
    Park SJ
    Catheter Cardiovasc Interv; 2011 Jan; 77(1):13-4. PubMed ID: 21181967
    [No Abstract]   [Full Text] [Related]  

  • 19. The AXXESS™ self-expanding biolimus A9™ eluting stent system for coronary bifurcation lesions.
    Dubois CL; Wijns W
    EuroIntervention; 2010 Dec; 6 Suppl J():J130-4. PubMed ID: 21930477
    [No Abstract]   [Full Text] [Related]  

  • 20. Vascular restoration therapy: the fourth revolution in interventional cardiology and the ultimate "rosy" prophecy.
    Wykrzykowska JJ; Onuma Y; Serruys PW
    EuroIntervention; 2009 Dec; 5 Suppl F():F7-8. PubMed ID: 22100680
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.